Sarcoma | Osteosarcoma
B6BmSc2 derived syngeneic murine osteosarcoma, derived from automatically transformed bone marrow derived murine mesenchymal stem cells (high passage = 50+), due to its origin (Black 6 mice) it can be used to generate syngrafts in Bl6 mice for further validation in more complex vertebrate models. Continue reading B6BmSc2 derived syngeneic murine osteosarcoma
Sarcoma | Osteosarcoma
Mammary carcinoma | Triple negative
Sarcoma | Osteosarcoma
osteosarcoma
Breast Cancer | Triple Negative
Between 10-20% of the human breast cancers are considered Triple Negative Breast Cancer (TNBC), which means that the tumour cells do not express the receptors for estrogen, progesterone, and Her2. In practice, that means that anticancer drugs that target these receptors or hormone therapy will not be effective. Continue reading MDA-MB231B1 Triple Negative Breast Cancer (bone tropic)